OHM Holdings Officially Joins the Western Smart Biomanufacturing Innovation Center Building a Global Hub for AI × Synthetic Biology

■  Company Overview

A Global Ingredients Platform, Powered by AI ＆ Synthetic Biology

OHM Holdings is a globally focused innovative ingredients platform driven by AI and synthetic biology technology, delivering high-value functional ingredients and customized solutions across five key sectors: Sports Nutrition, Natural Sugar Alternatives, Natural Pigments, Advanced Materials, and General Wellness, supported by 8 proprietary product pipelines.

OHM operates under a dual China–US engine strategy with a fully integrated supply chain, combining U.S.-based cutting-edge R&D and intellectual property strengths with China’s industrial scale-up capabilities. Its core competitive moat is built on the pillars of Science, Intellectual Property, and Speed.

■  Corporate Structure

Three Core Entities, One Integrated Vision

Omni Ingredients

North American operating subsidiary responsible for global supply chain integration and commercial operations in the North American market.

OHM Innovation

Controlling subsidiary responsible for AI model training, synthetic biology R&D, formulation innovation, and high-end manufacturing.

Aegis Wellness

Consumer brand subsidiary focused on the development and commercialization of premium dietary supplements.

■  Strategic Partnership

Deep Integration with the Innovation Center

Following this official registration, OHM Holdings will be deeply integrated into the Center’s R&D and pilot-scale production systems. Leveraging the Center’s strengths in synthetic biology, green biomanufacturing, and industry–academia–research collaboration, OHM will accelerate process optimization, scale-up production, and market expansion for its core pipeline compounds, including Salidroside, Phenyllactic Acid, and Pipecolic Acid.

OHM Holdings also plans to establish the core R&D and advanced manufacturing functions of its subsidiary OHM Innovation in China, working jointly to build a globally influential innovation hub for AI-driven synthetic biology.

■  Leadership Remarks

Voices from Both Sides

“The Western Smart Biomanufacturing Innovation Center offers one of China’s premier synthetic biology R&D and pilot platforms, along with a highly dynamic industrial innovation ecosystem. OHM looks forward to deepening this partnership to accelerate the localization and global export of innovative ingredients, and to jointly drive high-quality development in the health and biomanufacturing industries.”

— Dr. Zhao Jikai, CTO — OHM Holdings Inc.

“OHM Holdings brings world-leading AI × synthetic biology capabilities and proven commercial expertise to the Center. Their presence will further strengthen our leadership in high-end ingredient manufacturing, the green bioeconomy, and export-oriented growth. The Center is fully committed to supporting OHM’s establishment and expansion in China.”

— Wang Dan, Director — Western Smart Biomanufacturing Innovation Center

■  Looking Ahead

Four Pillars of Future Collaboration

Both parties will deepen cooperation across four strategic areas, with the shared ambition of positioning Chongqing as a flagship center for synthetic biology and biomanufacturing, not only in Western China, but on the global stage.